Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
AUTOR(ES)
Mangham, D C
RESUMO
It has been proposed that immunostaining with PC10, a monoclonal antibody against proliferating cell nuclear antigen (PCNA), is of prognostic value in gastric carcinoma. Gastric carcinomas from a series of 90 patients in whom survival data were known have been studied. There was no relation between the degree of PC10 immunostaining assessed semiquantitatively and survival.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=502033Documentos Relacionados
- Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
- Proliferating cell nuclear antigen (PCNA) and p53 protein expression in ameloblastoma and adenomatoid adontogenic tumor
- Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
- p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
- Upstream sequences of rice proliferating cell nuclear antigen (PCNA) gene mediate expression of PCNA-GUS chimeric gene in meristems of transgenic tobacco plants.
